Clinical evidence that more precisely defined dose distributions will improve cancer survival and decrease morbidity.
Keall
Paul J
PJ
Williamson
Jeffrey F
JF
D003362:Cost-Benefit Analysis / Q000379:methods*; D004583:Electrons; D020450:Heavy Ions; D006801:Humans; D008280:Magnetics; D009369:Neoplasms / Q000401:mortality* / Q000532:radiotherapy; D019047:Phantoms, Imaging; D011874:Radiometry / Q000379:methods*; D011878:Radiotherapy / Q000191:economics / Q000379:methods; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy / Q000191:economics* / Q000379:methods*; D018570:Risk Assessment / Q000379:methods